A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways

A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways

GV1001, a human telomerase reverse transcriptase catalytic subunit-derived 16-mer peptide, has been developed as a novel anticancer vaccine against various cancers including pancreatic cancer. In the current study, we demonstrate the regulatory roles and mechanisms of GV1001 in endothelial cell resp...

Full description

Bibliographic Details
Main Authors: Jae Hyeon Kim, Young-Rak Cho, Eun-Kyung Ahn, Sunho Kim, Surim Han, Sung Joon Kim, Gyu-Un Bae, Joa Sub Oh, Dong-Wan Seo
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Translational Oncology
Subjects:
GV1001
Telomerase-derived peptide
Angiogenesis
VEGF
Non-small cell lung cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322002054

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322002054

Similar Items